Patent · US Active

Disubstituted phthalazine hedgehog pathway antagonists

US9000023B2 · kind B2 · utility

5Cited by
2References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 21, 2012
Grant dateApr 7, 2015
Priority date
Expiry dateJan 17, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides novel 1,4-disubstituted phthalazine hedgehog pathway antagonists useful in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.